Multiple mechanisms involved in diabetes protection by lipopolysaccharide in non-obese diabetic mice

Toxicology and Applied Pharmacology

Volumn 285, Issue 3, 2015, Pages 149-158

  Wang, Jun ^a,b   Cao, Hui ^a   Wang, Hongjie ^c   Yin, Guoxiao ^a   Du, Jiao ^a   Xia, Fei ^a   Lu, Jingli ^a   Xiang, Ming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

Dendritic cells; Non obese diabetic mice; Regulatory T cells; Toll like receptor 4; Type 1 diabetes

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88; TLR4 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; FEMALE; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PHENOTYPE; REGULATORY T LYMPHOCYTE; SPLEEN; SYNTHESIS; T LYMPHOCYTE; TH1 CELL; ANIMAL; BLOOD; CELL DIFFERENTIATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; GENETICS; LYMPHOCYTE ACTIVATION; METABOLISM; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL;

BACTERIA (MICROORGANISMS); MUS;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELLS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DOWN-REGULATION; FEMALE; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MYELOID DIFFERENTIATION FACTOR 88; SPLEEN; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA;

EID: 84928815160     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.04.006     Document Type: Article

References (43)

1. Ardeshna K.M., Pizzey A.R., Devereaux S., Khwaja A. The PI3 kinase, p38 SAP kinase, and NF-kappa B signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000, 96:1039-1046.
2. Aumeunier A., Grela F., Ramadan A., Van L.P., Bardel E., Alcala A.G., Jeannin P., Akira S., Bach J.F., Thieblemont N. Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One 2010, 5.
3. Balasa B., Van Gunst K., Sarvetnick N. The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes. Clin. Immunol. 2000, 95:93-98.
4. Baumann B., Salem H.H., Boehm B.O. Anti-inflammatory therapy in type 1 diabetes. Curr. Diab. Rep. 2012, 12:499-509.
5. Bell C.M., Guo K., Wendel H.P. Endotoxin removal from albumin and saline solutions. Int. J. Artif. Organs 2007, 30:589-593.
6. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 2000, 12:20-26.
7. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B.R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J.N., Hecht F.M., Picker L.J., Lederman M.M., Deeks S.G., Douek D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12:1365-1371.
8. Caramalho I., Rodrigues-Duarte L., Perez A., Zelenay S., Penha-Goncalves C., Demengeot J. Regulatory T cells contribute to diabetes protection in lipopolysaccharide-treated non-obese diabetic mice. Scand. J. Immunol. 2011, 74:585-595.
9. Chung C.Y., Ysebaert D., Berneman Z.N., Cools N. Dendritic cells: cellular mediators for immunological tolerance. Clin. Dev. Immunol. 2013, 2013:972865.
10. Clanchy F.I.L., Sacre S.M. Modulation of toll-like receptor function has therapeutic potential in autoimmune disease. Expert. Opin. Biol. Ther. 2010, 10:1703-1716.
11. Csorba T.R., Lyon A.W., Hollenberg M.D. Autoimmunity and the pathogenesis of type 1 diabetes. Crit. Rev. Clin. Lab. Sci. 2010, 47:51-71.
12. Devaraj S., Dasu M.R., Rockwood J., Winter W., Griffen S.C., Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J. Clin. Endocrinol. Metab. 2008, 93:578-583.
13. Devaraj S., Dasu M.R., Park S.H., Jialal I. Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 2009, 52:1665-1668.
14. Devaraj S., Jialal I., Yun J.M., Bremer A. Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metab. Clin. Exp. 2011, 60:256-259.
15. Devaraj S., Tobias P., Jialal I. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. Cytokine 2011, 55:441-445.
16. Dobrovolskaia M.A., Medvedev A.E., Thomas K.E., Cuesta N., Toshchakov V., Ren T., Cody M.J., Michalek S.M., Rice N.R., Vogel S.N. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-B signaling pathway components. J. Immunol. 2003, 170:508-519.
17. Ehlers M.R., Nepom G.T. Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experience. Rev. Diabet. Stud. 2012, 9:359-371.
18. Eizirik D.L., Colli M.L., Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 2009, 5:219-226.
19. Fischer E.S., Bohm K., Lydeard J.R., Yang H.D., Stadler M.B., Cavadini S., Nagel J., Serluca F., Acker V., Lingaraju G.M., Tichkule R.B., Schebesta M., Forrester W.C., Schirle M., Hassiepen U., Ottl J., Hild M., Beckwith R.E.J., Harper J.W., Jenkins J.L., Thoma N.H. Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature 2014, 512:49-53.
20. Garay-Malpartida H.M., Mourao R.F., Mantovani M., Santos I.A., Sogayar M.C., Goldberg A.C. Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis. BMC Immunol. 2011, 12:18.
21. Giannoukakis N. Tolerogenic dendritic cells for type 1 diabetes. Immunotherapy 2013, 5:569-571.
22. Giannoukakis N., Phillips B., Finegold D., Harnaha J., Trucco M. Phase 1 (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011, 34:2026-2032.
23. Hong S., Li H., Qian J., Yang J., Lu Y., Yi Q. Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity. Clin. Exp. Immunol. 2012, 170:167-177.
24. Hubert P., Jacobs N., Caberg J.H., Boniver J., Delvenne P. The cross-talk between dendritic and regulatory T cells: good or evil?. J. Leukoc. Biol. 2007, 82:781-794.
25. In't Veld P. Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets 2011, 3:131-138.
26. In't Veld P. Insulitis in human type 1 diabetes: a comparison between patients and animal models. Semin. Immunopathol. 2014, 36:569-579.
27. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
28. Kondrashova A., Hyoty H. Role of viruses and other microbes in the pathogenesis of type 1 diabetes. Int. Rev. Immunol. 2014, 33:284-295.
29. Li M., Song L., Gao X., Chang W., Qin X. Toll-like receptor 4 on islet beta cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes. Exp. Mol. Med. 2012, 44:260-267.
30. Lucas K., Maes M. Role of the Toll like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol. Neurobiol. 2013, 48:190-204.
31. Mohammad M.K. Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int. Immunol. 2006, 18:1101-1113.
32. Morel P.A. Dendritic cell subsets in type 1 diabetes: friend or foe?. Front. Immunol. 2013, 4:415.
33. Pasquali L., Giannoukakis N., Trucco M. Induction of immune tolerance to facilitate beta cell regeneration in type 1 diabetes. Adv. Drug Deliv. Rev. 2008, 60:106-113.
34. Sousa C.R. Essay - dendritic cells in a mature age. Nat. Rev. Immunol. 2006, 6:476-483.
35. Tan J.K., O'Neill H.C. Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity. J. Leukoc. Biol. 2005, 78:319-324.
36. Verdijk R.M., Mutis T., Esendam B., Kamp J., Melief C.J.M., Brand A., Goulmy E. Polyriboinosinic polyribocytidylic acid (poly(I: C)) induces stable maturation of functionally active human dendritic cells. J. Immunol. 1999, 163:57-61.
37. Vives-Pi M., Somoza N., Fernandez-Alvarez J., Vargas F., Caro P., Alba A., Gomis R., Labeta M.O., Pujol-Borrell R. Evidence of expression of endotoxin receptors CD14, Toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin. Exp. Immunol. 2003, 133:208-218.
38. Wang X., Zhang A.X., Liu Y., Chen S., Feng Z.Q., Shang W.B., Maziarz M., Radtke J., Hampe C.S. Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse. PLoS One 2012, 7:e32515.
39. Wang J., Lu J., Lan Y., Zhou H., Li W., Xiang M. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways. J. Ethnopharmacol. 2013, 146:379-392.
40. Watanabe S., Kumazawa Y., Inoue J. Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD14. PLoS One 2013, 8:e60078.
41. Xiang M., Hou W.R., Xie S.N., Zhang W.D., Wang X. Immunosuppressive effects of an ethyl acetate extract from Urtica dentata Hand on skin allograft rejection. J. Ethnopharmacol. 2009, 126:57-63.
42. Xue M., Dervish S., Harrison L.C., Fulcher G., Jackson C.J. Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice. J. Biol. Chem. 2012, 287:16356-16364.
43. Zoka A., Muzes G., Somogyi A., Varga T., Szeman B., Al-Aissa Z., Hadarits O., Firneisz G. Altered immune regulation in type 1 diabetes. Clin. Dev. Immunol. 2013, 2013:254874.